SEC Comment Letter for AC Immune SA (ACIU) (CIK 0001651625) (ACIU) — Oct 29, 2020
AC Immune SA (ACIU) (CIK 0001651625)
Date: Oct. 29, 2020 · CIK: 0001651625 · Accession: 0000000000-20-010280
AI Filing Summary & Sentiment
File numbers found in text: 333-249655
Letter
United States securities and exchange commission logo October 29, 2020 Andrea Pfeifer Chief Executive Officer AC Immune SA EPFL INNOVATION PARK Building B 1015 Lausanne Switzerland Re:AC Immune SA Registration Statement on Form F-3 Filed October 23, 2020 File No. 333-249655 Dear Dr. Pfeifer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Derek J. Dostal
Show Raw Text
United States securities and exchange commission logo
October 29, 2020
Andrea Pfeifer
Chief Executive Officer
AC Immune SA
EPFL INNOVATION PARK
Building B
1015 Lausanne
Switzerland
Re:AC Immune SA
Registration Statement on Form F-3
Filed October 23, 2020
File No. 333-249655
Dear Dr. Pfeifer:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Derek J. Dostal